New research suggests a potential link between gut health, vitamin deficiencies, and the progression of Parkinson’s disease, offering a novel avenue for treatment and management of the neurodegenerative disorder. A study from Nagoya University in Japan found associations between altered gut bacteria and reduced levels of vitamins B2 and B7 in Parkinson’s patients . This connection is prompting investigation into whether simple vitamin supplementation could alleviate symptoms and slow the disease’s advance, while also addressing the significant economic burden Parkinson’s places on patients and healthcare systems.
Gut Bacteria Changes Linked to Vitamin Deficiencies in Parkinson’s Disease, Potential for New Treatments
Changes in gut bacteria composition appear to be associated with reduced levels of vitamin B2 (riboflavin) and vitamin B7 (biotin) in individuals with Parkinson’s disease, according to new research. These findings suggest that supplementation with these B vitamins could potentially offer a therapeutic approach to managing the condition and slowing its progression.
“Supplementation targeting riboflavin and biotin is promising as a potential therapeutic avenue for alleviating Parkinson’s symptoms and slowing disease progression,” said researcher Hiroshi Nishiwaki of Nagoya University in Japan, in a press release in May 2024. Parkinson’s disease is a progressive neurological disorder that affects movement, and finding new ways to manage its symptoms and slow its course is a major focus of medical research.
Vitamin Deficiencies Impact Gut Health
The research also revealed a connection between the deficiency of these two B vitamins and a decrease in short-chain fatty acids (SCFAs), crucial compounds produced by gut bacteria when they break down dietary fiber. Additionally, levels of polyamines – molecules essential for maintaining a healthy gut lining – were also found to be reduced.
“A deficiency in polyamines and short-chain fatty acids can lead to a thinning of the intestinal lining, increasing intestinal permeability. Both of these have been observed in Parkinson’s disease,” Nishiwaki explained in the press release. “This increased permeability exposes nerves to toxins, contributing to the abnormal clumping of alpha-synuclein, activating immune cells in the brain, and leading to long-term inflammation.” Intestinal permeability refers to how easily substances can pass through the intestinal wall, while alpha-synuclein is a protein in the brain involved in nerve cell communication.
Parkinson’s Disease Carries Significant Economic Burden
The financial impact of Parkinson’s disease is substantial. A 2012 study showed that healthcare costs for Parkinson’s patients in Sweden reached nearly 2 billion Swedish krona (approximately $185 million USD) in 2009. The study, as reported by Vetenskap & Hälsa, indicated that care and medication costs totaled 1.7 billion krona (approximately $157 million USD), or 76,000 krona (approximately $6,980 USD) per patient in 2009. Fifty-two percent of these costs were attributed to inpatient care, 27 percent to primary care visits, and 21 percent to medications.
A 2021 study examining the broader economic costs of Parkinson’s disease revealed that a significant portion of expenses fall outside of traditional healthcare budgets, according to Neurologisk Tidskrift in June 2022. The study found that patients, their families, and municipalities bear the largest share of the financial burden through lost productivity, informal caregiving, and municipal social services.
As the proportion of older adults with Parkinson’s disease increases, so too does the overall cost of care and support, both for individuals and for society. Therefore, identifying cost-effective treatments, such as vitamin supplementation, could have a significant impact on healthcare systems and patient well-being. If a simple treatment with B vitamins could help patients with Parkinson’s disease, there is substantial potential for cost savings for patients, healthcare systems, and society as a whole.
Read more on E55: Poor Sleep – Expensive for Society and Expensive for Your Brain
Read more from E55 – our newsletter is free:
